University of Nottingham Engineers Adaptable Nanoscale Platform for RNA Delivery
**New Drug Delivery Platform Shows Promise for Genetic Medicines**
Researchers have engineered an adaptable materials platform designed for the safe and efficient delivery of various genetic medicines. The innovation has the potential to expedite the creation of next-generation vaccines, cancer therapies, and gene-silencing medications.
The University of Nottingham’s School of Pharmacy developed the new drug delivery platform. The platform employs modular building blocks that self-assemble with Ribonucleic acid (RNA), resulting in the formation of nanoscale delivery particles.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: February 27, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]LATEST
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10







